Department of Clinical Sciences, Influenza Centre, University of Bergen, Norway.
Department of Anesthesia and Intensive Care, Haukeland University Hospital, Bergen, Norway.
Scand J Immunol. 2021 Aug;94(2):e13045. doi: 10.1111/sji.13045. Epub 2021 Jun 10.
There is limited knowledge of influenza-specific immune responses and their kinetics in critically ill patients. We investigated humoral and cellular immune responses after critical influenza A/H1N1 infection and hypothesized that dysfunctionality or absence of immune responses could contribute to more severe illness. We followed 12 patients hospitalized with severe influenza infection; the majority admitted to intensive care unit (ICU). Blood samples were collected at days 10 and 19 and at 5 months. Antibody responses to surface glycoproteins haemagglutinin (HA) and neuraminidase (NA) of A/H1N1pdm09 were quantified by haemagglutination inhibition (HAI), microneutralization (MN), Enzyme-linked immunosorbent assay (ELISA) and Enzyme-linked lectin assay (ELLA). Influenza-specific antibody levels and avidity were measured separately for head and stalk domains of H1. Cytokine secreting CD4 and CD8 T cell responses to conserved influenza epitopes (M1, NP and PB1) were analysed by FluoroSpot. Overall, the patients retained a high level of functional HA- and NA-specific antibodies over the study period. During the acute phase (up to 3 weeks from symptom onset), antibodies specific to H1 stalk increased earlier and were present in higher amount compared with H1 head-specific antibodies. The NA-specific antibodies and the non-neutralizing HA-specific antibody response for H1 head and H1 full-length showed a significant decline from acute to convalescent phase. Despite high total IgG concentrations, avidity to H1 head and H1 full-length protein remained low at all time points. Similarly, CD8 T cell responses were continuously measured at low levels. In conclusion, our study found that critically ill patients were characterized by low HA-specific antibody avidity and CD8 T cell response.
关于危重症流感患者的流感特异性免疫应答及其动力学,我们知之甚少。本研究旨在调查重症甲型 H1N1 流感感染后的体液和细胞免疫应答,并假设免疫应答功能障碍或缺失可能导致更严重的疾病。我们对 12 例因严重流感感染住院的患者进行了随访,其中大多数患者入住重症监护病房(ICU)。在第 10 天和第 19 天以及 5 个月时采集血样。通过血凝抑制(HAI)、微量中和(MN)、酶联免疫吸附试验(ELISA)和酶联凝集素测定法(ELLA)定量测定针对 A/H1N1pdm09 表面糖蛋白血凝素(HA)和神经氨酸酶(NA)的抗体应答。分别对头和茎结构域的 H1 测量流感特异性抗体水平和亲和性。通过 FluoroSpot 分析针对保守流感表位(M1、NP 和 PB1)的 CD4 和 CD8 T 细胞应答中细胞因子的分泌。总体而言,在整个研究期间,患者保留了高水平的功能性 HA 和 NA 特异性抗体。在急性期(发病后 3 周内),与 H1 头特异性抗体相比,针对 H1 茎的抗体更早增加且数量更高。从急性期到恢复期,NA 特异性抗体和非中和性 H1 头特异性抗体应答的 H1 头和全长 H1 均显著下降。尽管总 IgG 浓度较高,但 H1 头和全长 H1 蛋白的亲和力仍在所有时间点保持较低。同样,CD8 T 细胞应答也持续以低水平测量。总之,本研究发现,危重症患者的特点是低 HA 特异性抗体亲和力和 CD8 T 细胞应答。